Omnitrope Pen 10 approved for growth hormone deficiency

The FDA has approved Sandoz’s Omnitrope Pen 10 (somatropin [rDNA origin] injection) for the treatment of growth failure in children and growth hormone deficiency in adults. This 10mg dosage strength will be available in addition to Omnitrope Pen 5, the 5mg dosage strength, available since March 2008.

For more information call (609) 627-8500 or visit